Cargando…
Electrochemiluminescence Assays for Human Islet Autoantibodies
Pinpointing islet autoantibodies associated with type 1 diabetes (T1D) leads the way to project and deter this disease in the general population. A novel ECL assay is a nonradioactive fluid phase assay for islet autoantibodies with higher sensitivity and specificity than the current 'gold'...
Autores principales: | Gu, Yong, Zhao, Zhiyuan, Miao, Dongmei, High, Hilary, Yang, Tao, Yu, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933252/ https://www.ncbi.nlm.nih.gov/pubmed/29630056 http://dx.doi.org/10.3791/57227 |
Ejemplares similares
-
Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay
por: Gu, Yong, et al.
Publicado: (2017) -
Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity
por: Yu, Liping, et al.
Publicado: (2013) -
GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes
por: Miao, Dongmei, et al.
Publicado: (2013) -
Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function
por: Zhu, Yuxiao, et al.
Publicado: (2020) -
High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes
por: Jia, Xiaofan, et al.
Publicado: (2021)